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Abstract
Objective: To quantify the concentration of sulfated glycosaminoglycans (GAGs) concentration in the synovial fluid (SF) of knees with 
chronic anterior cruciate ligament (ACL) rupture and to identify possible associations between GAG concentration in SF and the time 
elapsed since rupture and degree of chondral injury. Method: Fourteen adult male subjects with total unilateral ACL rupture, which 
had occurred between 5 and 144 months earlier, were assessed. All subjects underwent joint aspiration; it was possible to collect 
SF from ten individuals. The samples were quantified to determine the GAG concentration using dimethylmethylene blue (DMMB) 
staining. The degree of chondral injury was macroscopically evaluated using the modified Mankin histological scale. Spearman 
correlation test (p≤ 0.05) was used to evaluate the association between GAG concentration and chondral injury, and Pearson 
correlation test (p≤ 0.05) was used to evaluate the association between GAG concentration and the time elapsed since rupture. 
Results: The GAG concentration in SF showed a mean variation of 73.84 ± 40.75 µg/ml, with a mean time of 40.4 ± 40.3 months since 
the rupture. There was no correlation between GAG concentration and time since the rupture (r= -0.09, p= 0.81). The chondral injury 
grades found were 0, 1, 4 and 5. There was no correlation between chondral injury grade and GAG concentration in SF (r= -0.41, 
p= 0.24). Conclusion: After at least 5 months, the GAG concentration in SF from knees with ACL rupture is independent of the time 
elapsed since rupture and/or the severity of chondral injury.  
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Resumo
Objetivo: Quantificar a concentração de glicosaminoglicanas sulfatadas (GAGs) no líquido sinovial (LS) de joelhos com ruptura crônica 
do ligamento cruzado anterior (LCA) e identificar uma possível correlação entre a concentração de GAGs no LS e o tempo pós-ruptura e 
grau de lesão condral. Métodos: Foram avaliados 14 indivíduos adultos do sexo masculino com ruptura total unilateral do LCA, ocorrida 
entre cinco a 144 meses. Todos os sujeitos foram puncionados, sendo possível a coleta de LS em dez indivíduos. As amostras foram 
quantificadas para determinar a concentração de GAGs usando a coloração azul de dimetilmetileno, método descrito por Farndale21. O 
grau de lesão condral foi macroscopicamente avaliado pela escala histológica de Mankin modificada por Messner14. As correlações entre 
concentração de GAGs e lesão condral foram feitas pelo teste de correlação de Sperman (p< 0,05) e a concentração de GAGs e tempo 
pós-ruptura pelo teste de correlação de Pearson (p< 0,05). Resultados: Concentração de GAGs no LS apresentou variação média de 
73,84 ± 40,75µg/mL, sendo o tempo médio pós-ruptura de 40,4 + 40,3 meses. Não houve correlação entre concentração de GAGs e o 
tempo pós-ruptura (r= -0,09, p= 0,81). Os graus de lesão condral encontrados foram de 0, 1, 4 e 5. Não houve correlação entre grau de 
lesão condral e a concentração de GAGs no LS (r= -0,41, p= 0,24). Conclusões: Após no mínimo cinco meses, a concentração de GAGs 
no LS de joelhos com ruptura do LCA independe do tempo pós-ruptura e/ou do grau de lesão condral. 
Palavras-chaves: glicosaminoglicanas; cartilagem; ligamento cruzado anterior; líquido sinovial; lesão condral.
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Introduction 
Rupture of the anterior cruciate ligament (ACL) is a common 
injury representing 70% of all ligament injuries in sports practice. 
In Brazil, soccer is considered as the activity that causes most 
injuries to this ligament1. ACL injuries bring various sequelae to 
the knee joint, including compromised static stability. The con-
sequence is alterations to knee kinematics and motor function, 
thereby triggering joint overload and subsequent micro-injuries 
to the joint cartilage that lead to the onset of osteoarthritis (OA)2. 
However, the mechanism responsible for the degeneration of 
the joint cartilage following ACL rupture is not well understood 
yet. Mechanical instability does not seem to be the only factor 
responsible for the development of post-traumatic OA, since 
biochemical disorders may also be involved3.
During the acute phase of ACL injury, the concentration 
of the synovial fluid (SF) increases due to the presence of ma-
cromolecules and fragments of macromolecules derived from 
destructive processes in the cartilage matrix. Macromolecular 
changes in SF content can be observed, since under normal 
conditions they are virtually absent4-,6. Together with the ACL 
injury, various components of the extracellular matrix (ECM) 
are found in the SF, such as cartilage oligomeric matrix protein 
(COMP), stromelysin, proteins and proteoglycan (PG) frag-
ments such as sulfated glycosaminoglycans (GAGs)7,8, as well 
as inflammatory cells, synoviocytes and free chondrocytes6,9.
Studies by Tiderius et al.3 and Dahlberg et al.10 showed in-
creased GAG concentrations in the SF during the acute phase 
of ACL rupture, in comparison with fluid sampled from the 
knees of healthy athletes11. Moreover, Hazell et al.12 observed 
more than three times increases in GAGs and PGs in the SF 
of traumatized knees, compared to the amount found in the 
contralateral knee. Ratcliffe et al.13 observed increased PG frag-
ment levels in the joint fluids during the acute phase, although 
the same increase was not found in patients with chronic di-
seases such as OA. In addition, Messner et al.14 found a normal 
value of 21µg/ml for GAGs in the SF from control rabbit knees. 
However, Taskiran et al.15 analyzed the GAG concentration in 
the SF from control subject knees without any kind of ligament 
injury and found a normal value of 13.1µg/ml.
During the chronic phase of ACL rupture, a reduction in SF 
volume occurs, although some studies have reported that PG 
fragment concentrations remain high even during the late phase 
following joint trauma7,8,12,15,16. However, during the chronic 
phase of ACL rupture, the onset of chondral injury is expected. 
Thus, the GAG concentration during this phase might be related 
not only to the ligament injury but also to the chronic changes 
found in the cartilage tissue, secondary to the chondral injury. 
However, the GAG concentrations in chronic and acute trauma-
tic knee injuries, and in chondral injuries, are not well known.
When searching for associations between GAG concentra-
tions and the periods that are considered acute and chronic, 
we could not find a consensus among the author. Hazell et al.12 
detected increased quantities of chondroitin sulfate (a type of 
sulfated glycosaminoglycan marker antibody) and total GAGs 
in patients who had suffered ACL and/or meniscal injuries up 
to 10 months earlier. However, Tiderius et al.3, in their analy-
sis of subjects with ACL rupture up to 22 days earlier, found 
no correlation between injury duration and estimated GAG 
content in the joint cartilage. Taskiran et al.15 observed both 
changed and unchanged GAG concentrations six months after 
surgical ACL reconstruction. The concentrations of PG frag-
ments showed significant reductions until the sixth month, 
when the values leveled out. Even so, these values remained 
above control values.
GAG concentrations are also not well known in relation 
to the onset and degree of chondral injury following ACL rup-
ture. An investigation by Myers et al.17 showed no associtation 
between the concentration of PG fragments and the degree of 
severity of joint cartilage injury in dogs following ACL rupture, 
analyzed four and eight months after the injury. However, 
other studies showed the opposite relationship between PG 
concentration in the SF and the magnitude of joint space loss 
seen in knee X-rays11,18,19.
Considering that GAG molecules are known to be metabo-
lic markers for the joint cartilage, and the fact that they can 
be quantified and used to indicate changes in cartilage matrix 
homeostasis, these cartilage components can be used as markers 
for joint disease progression3,17,20. Therefore, the aims of the 
present study were to quantify GAG concentrations in knee 
SF in subjects with chronic ACL rupture and to identify any 
possible association between GAG concentrations in SF and 
the time since rupture and degree of chondral injury. 
Methods 
This study included ten male patients (mean age 29 ± 
5.4 years) presenting total unilateral rupture of the ACL, with 
or without associated meniscal injury, who sought orthopedic 
medical assistance in the city hospital where this study was 
developed over a consecutive eighteen-month period and for 
whom surgical arthroscopic ligament reconstruction was in-
dicated. To be included in the sample, patients had to present 
chronic ligament rupture, have suffered their injury at least five 
months earlier, and undergo arthroscopic reconstruction by a 
physician. Four subjects who underwent preoperative physical 
therapy during the last six months before SF collection, or who 
suffered recurrent knee sprain within 30 days before SF collec-
tion, or who had stroke and/or joint pain, as well as those for 
whom SF collection was not possible due to the small volume 
of synovial fluid inside the joint, were excluded from the study. 
For each patient, a physical evaluation sheet was filled in 
before data collection, to ensure that the inclusion and exclu-
sion criteria were met, and to ensure that the reasons for and 
objectives of the study were clearly understood. Patients sig-
ned an informed consent form and were given explanations as 
required by the Ethics Committee of the Universidade Federal 
de São Carlos (Protocol: 143/04) (National Health Council Re-
solution No. 196/96).
Macroscopic Evaluation of the Joint Cartilage 
The macroscopic appearance of the lateral and medial joint 
surfaces of the femoral and tibial condyles of knees with ACL 
rupture were evaluated based on arthroscopic findings by the 
orthopedist in charge. The modified histological Mankin scale14 
was used after sampling the SF and immediately before liga-
ment reconstruction. The chondral injury scores were evalua-
ted as follows: (0) normal cartilage; (1) fibrillation and surface 
irregularities; (2) surface irregularities and formation of pan-
nus; (3) formation of surface fissures; (4) deep but local fissures, 
down to the subchondral bone; (5) large defects on the joint 
surface, down to exposure of the subchondral bone; (6) total 
loss of joint cartilage in the areas of weight-bearing unload. The 
score for the degree of tissue destruction was defined using the 
maximum score parameter from the highest degree of chon-
dral injury (0–6 scale) found in any one of the four regions of 
femoral or tibial condyles. 
The evaluation was conducted blindly to GAG concentra-
tion in the synovial fluid.
Synovial fluid aspiration
Synovial fluid was aspirated from the suprapatellar bursa 
before carrying out the ACL reconstruction surgery, for analy-
sis. First, the injured knee was shaved on its anterolateral face 
and spinal anesthesia was applied. Then, the orthopedist in 
charge  inserted a needle in the lateral region of the knee and 
the synovial fluid was arthroscopically collected at the time of 
surgery. After collection, the fluid from each subject was stored 
in a properly closed and labeled plastic container and the sam-
ples were quantified for volume. Then, a 3.8% sodium citrate 
solution was added and the samples were stored at minus 20°C 
until they were analyzed.
Analysis of Sulfated Glycosaminoglycans
The samples obtained were quantified for GAG con-
centration using the dimethylmethylene blue (DMMB) dye 
technique, in accordance with the method described by 
Farndale21. The SF samples were centrifuged at 8,000 rpm for 
10 minutes and the supernatant liquid was diluted ten times 
with 0.05M phosphate buffer (pH 7.0). Samples of 100 µl were 
digested with 100 µl of buffer containing 2.6 mM papain, 0.6 
mM L-cysteine, 2 mM EDTA, and 5 mM NaCl. After incubating 
for two hours at 65°C, sodium chloride was added ( final NaCl 
concentration: 0.5M); the volume was completed to 250 µl, 
and an aliquot of 100 µl was withdrawn. Once the sample was 
ready to be examined, 2.5 ml of DMMB reagent solution was 
added to the material and, after a few seconds, the absorbance 
was measured at λ = 526 nm, using a spectrophotometer. 
To determine the GAG concentration, a comparison was 
made between the GAG concentration values measured in SF 
samples and the values on a standard curve that was made 
prior to the analysis using known concentrations of chondroi-
tin sulfate. 
Statistical analysis
Pearson correlation coefficient was used to evaluate the as-
sociation between the length of time since rupture on the GAG 
concentration in SF, and the Spearman rank correlation coeffi-
cient was used to evaluate the relationship between chondral 
injury degree and GAG concentration in SF. For all statistical 
analyses, the significance level was set at 5% (α = 0.05). 
Results 
All the patients with chronic ACL ruptures were in the 22 - 
40 year age range (mean age 29.5 ± 5.4 years). It was possible to 
obtain SF by joint aspiration from 10 subjects, of whom six had 
their injuries in the right knee. The mean time since the rupture 
was 40.4 ± 40.3 months (range: 5 - 144 months) (Table 1). 
The mean volume of aspirated SF was 4.4 ml ± 4.4 ml 
(range: 0.8 - 12 ml) (Table 1). All aspirated liquids were citrus 
yellow in color at the time of collection. A single patient 
(Patient I) presented blood strands mixed with the collected 
liquid, but this was due to sample contamination by the nee-
dle used for collecting the material through the skin. Another 
four patients presented fragments or free bodies resulting 
from the joint cartilage injury, suspended in the fluid (data 
not shown). During the arthroscopy procedure, medial me-
niscal injury was observed in five subjects, of whom three also 
had lateral meniscal injury.
Absorptiometric analysis on the samples with DMMB sho-
wed that the mean GAG concentration was 73.8 ± 40.7µg/ml 
(range: 25.2 – 158.0 µg/ml). The individual values are shown 
in Table 1. The results showed that there was no correlation 
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between the GAG concentration and the time since the rup-
ture (r= -0.09, p= 0.81) (Figure 1).
The macroscopic evaluation of the joint cartilage showed 
that in three patients (Patients B, C and H) no change was 
found on the cartilage surface, while two other patients (Pa-
tients F and J) had deep local injuries. Chondral injury scores of 
2, 3 and 6 were not observed in this study. There was no corre-
lation between chondral injury degree and GAG concentration 
in SF (r= -0.41, p= 0.24) (Figure 2). 
Discussion 
The present study has shown the existence of variation in 
the SF volume found by joint aspiration in knees with total 
ACL rupture, either with or without associated meniscal injury. 
*For all patients, the mean ± standard deviation values are respectively the following: age, 29.5 ± 5.4 years; height, 172.5 ± 7.8cm; weight, 77.6 ± 8.7kg; time since rupture, 40.4 ± 40.3 months; 
GAGs concentration in the SF, 73.8 ± 40.7µg/mL; amount of SF present in the knee, 4.4 ± 4.4 mL. 
†M: medial meniscus; L: lateral meniscus. 
Chondral injury scores: (0) normal cartilage; (1) fibrillation and surface irregularities; (2) surface irregularities and formation of pannus; (3) formation of surface fissures; (4) deep, but 
local, fissures, down to exposure of the subchondral bone; (5) large defects on the joint surface down to exposure of the subchondral bone; (6) total loss of joint cartilage in the areas 
of weight unload.
Table 1. Characteristics of patients with anterior cruciate ligament injury*.
Patients
Age
(years)
Height
(cm)
Weight
(kg)
Injured knee
Time since 
ACL rupture  
(months)
GAGs 
content in 
synovial fluid
(µg/mL)
Synovial 
fluid in knee
(mL)
Meniscal 
injury†
Chondral 
injury score
A 24 164 64 L 5 41.0 9.0 M + L 4
B 29 173 75 L 6 96.9 0.8 Absent 0
C 22 183 93 R 16 158.0 0.8 Absent 0
D 37 165 73 R 18 25.2 12.0 L 4
E 30 175 85 R 33 35.3 2.0 Absent 1
F 28 167 82 L 36 99.1 4.0 M + L 5
G 40 186 83 R 43 59.2 11.0 M + L 1
H 30 169 72 L 47 105.2 3.0 L 0
I 27 178 81 R 56 51.1 1.0 M 1
J 28 165 68 R 144 67.3 1.0 M 5
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Figure 1. Concentration curve (µg/mL) of GAGs in the synovial fluid in 
ten patients with ACL injury as a function of time since rupture (months) 
(r= -0.0868, p< 0.812). 
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Figure 2. Concentration curve (µg/mL) of GAGs in the synovial fluid 
in ten patients with ACL injury as a function of chondral injury score 
(r= -0,41, p= 0,24).
Moreover, there was variation in GAG concentration in the SF 
from patients who suffered ACL rupture at least five months 
earlier and different chondral injury scores. On average, the 
volume of SF found in the injured joint in the present study 
was 4.4 ml. The synovial fluid in joint diseases may present 
variations in its composition and volume. The volume may be 
10-20 times higher than normal values, as a result of the greater 
production of inflammatory exudate, which mirrors the patho-
logical phenomenon that occurred in the joint22. 
According to Fawthrop et al.8, the volume of SF present in 
the human knee varies from 0.2 ml to 2 ml, and from 1 ml to 
50 ml in subjects with OA. A study by Tiderius et al.3 showed 
that the mean volume of SF found in patients with acute ACL 
rupture was 19 ml, due to the greater joint inflammatory in-
filtrate present during this phase, which was higher than the 
volume found in our study of chronic injury.
Glycosaminoglycans in synovial fluid after ACL rupture
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The mean GAG concentration found in the SF was 73.8 ± 40.7 
µg/ml (Table 1) in patients with chronic ACL rupture. Such va-
lues are higher than the normal levels for knees without previous 
joint injury that are described in the literature14,15. Few studies 
have found chondroitin sulfate levels in SF from the contralate-
ral knee that were within normal values. In addition to the diffi-
culty in obtaining SF from the contralateral joint, the use of the 
contralateral knee is not an advantage, since some patients with 
knee injury may change their gait and thus promotes abnormal 
loads on the contralateral knee. This would probably reduce the 
differences between the traumatized knee and the contralateral 
knee8,12 and the normal values obtained would not be reliable.
Several authors have reported increased quantities of anti-
bodies that are chondroitin sulfate markers, as well as increased 
GAG concentration, in patients with chronic knee injuries. These 
values remained elevated for many years after the trauma and 
thus were able to indicate not only the progression of the injury, 
but also its repair process12,15,23. In our study, subjects with a mi-
nimum time since the rupture of five months were evaluated, i.e. 
subjects presenting chronic ligament rupture. The mean GAG 
concentration found in the SF was higher than the normal levels 
described in the literature14,15. However, there was no correlation 
between the GAG concentration and the length of time since the 
rupture, which confirms the studies by Tiderius et al.3.
Our results showed that patients whose ruptures occurred more 
than four years earlier (Patients I and J) still presented GAG levels 
that were higher than normal values, thus confirming the available 
data in the literature. In humans, high levels of GAGs in the SF have 
been noticed in association with acute ACL and meniscal injury, as 
well in primary and post-traumatic OA10,14,17,24. The concentration 
increases to a maximum one week after the trauma, thereafter re-
ducing to a plateau level three to six months after the injury10,12,15,24. 
However, the concentrations of PG fragments still remain above 
the control values in many cases (up to four years after ligament 
rupture), thus indicating a possible biochemical disorder16,25.
A study by Uesaka et al.20 measured the concentration of 
chondroitin sulfate, and found higher values in the early sta-
ges of chondral injury. These values tended to reduce as the 
chondral injury advanced, thus indicating a possible inverted 
relationship between the concentration of this marker and 
the degree of joint degeneration. This confirmed the results 
obtained by Dahlberg et al.11, who also noticed an inverse rela-
tionship between the chondral injury score and the mean con-
centration of proteoglycan fragments in the SF of patients with 
ACL and/or meniscal injury. The reduction in proteoglycan 
fragment levels in the SF with increasing degree of chondral 
injury in OA probably results from the reduction in the amount 
of cartilage present in the joint11,20,26. 
Although the concentrations of the markers in the syno-
vial fluid seem to be derived from the joint cartilage, rather 
than from the GAGs present in the menisci and ligaments27, 
the results indicated that there was no correlation between 
the GAG concentration in the SF and the degree of chondral 
injury. Regardless of any associated meniscal injury, patients 
with ACL rupture presented a higher risk of post-traumatic 
chondral injury, which confirms previous studies18,28. However, 
the association between meniscal injury and the use of menis-
cectomy was considered to be the main factor responsible for 
the degenerative events in the joint cartilage29.
Experimental studies using OA models have shown that, 
immediately after the trauma, changes are noticed in the me-
tabolic, chemical and mechanical characteristics of the matrix, 
prior to the onset of macroscopic or radiological changes18. The 
function and complex structure of the normal joint cartilage can 
be altered even by minor traumas30. In addition, Nakayama et 
al.31 reported that the difficulties in interpreting proteoglycan 
fragments in the synovial fluid are due not only to their mole-
cular origin and the different tissues in the joint, but also to the 
fact that the clinical stage of the joint condition certainly has a 
different effect on each tissue. Further investigation is required 
to identify the origin of the proteoglycan fragments in the SF. 
We believe that using different types of biological markers will 
make it possible to properly monitor and treat pathological condi-
tions of the cartilage tissue. Many questions still remain regarding 
the GAG levels present in the synovial fluid as a form of prognosis 
for chondral injury. Different methods for quantifying GAGs are 
being studied, as well as individuals with different kinds of patho-
logical conditions and lengths of time since their injuries.
In spite of the high incidence of ACL injuries and the large 
number of papers published on the progression of chondral in-
jury secondary to ACL injuries, the number of ongoing studies 
investigating the levels of possible chondral injury markers such 
as sulfated glycosaminoglycans in chronic ACL injuries, as well as 
the association between these levels and the length of time since 
ligament injury and degree of cartilage degeneration, is still small.
Conclusions       
The results from this study show that, after a minimum five-
month period, the GAG concentration in the SF from knees with 
ACL rupture does not depend on the length of time since rupture 
and/or the degree of chondral. Nonetheless, it is accepted that a 
relationship exists between ACL injury, more pronounced pre-
sence of sulfated GAGs in the synovial fluid and chondral injury. 
This fact suggests that the detection of sulfated GAGs in the sy-
novial fluid from knees with ACL injury indicates joint cartilage 
degradation, thereby enabling early diagnosis of chondral injury 
and making it possible to start an early treatment schedule and 
lead to a better functional prognosis for patients.
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